clinical trial · NCT04622735
Nefopam/Paracetamol Fixed Dose Combination in Acute Pain After Impacted Third Molar Extraction
Unither Pharmaceuticals, France·phase3·completed·n = 321
Acute Painnefopam hydrochloride 30mg / paracetamol 500mg X2Paracetamol 500 Mg Oral Tablet X2Nefopam HCl 30 MG Oral Tablet X2
brief summary
This study aims to evaluate the analgesic efficacy of single and multiple doses of a new fixed dose combination of nefopam hydrochloride 30 mg and paracetamol 500mg taken orally in comparison to each single component.
started
Feb 22, 2020
primary completion
Oct 12, 2022
completion
Oct 20, 2022
last updated
Nov 27, 2024
official title
A Comparative, Randomized, Double-blind, 3-arm Parallel, Phase III Study to Evaluate the Efficacy and Safety of a Fixed Dose Combination of Nefopam/Paracetamol Taken Orally in Moderate to Severe Pain After Impacted Third Molar Extraction
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol